OLD GREENWICH, Conn.--(BUSINESS WIRE)-- Ellington Financial Inc. (EFC) (the “Company”) announced today that it has priced an underwritten public offering of 8,775,000 shares of its common stock for ...
SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that MYQORZO™ (aficamten) is now available for prescription in 5 mg, 10 mg, 15 ...
TORONTO—Today’s news that conditional federal permits have been granted to relocate Marineland’s whales and dolphins to four US aquariums marks another disappointing turn in the Niagara Falls theme ...
This chapter samples positions for and against physician assisted suicide. It includes statements in the United Kingdom and the United States of America (California) and makes special note of ...
CAMAS, Wash.--(BUSINESS WIRE)-- nLIGHT, Inc. (LASR), a leading provider of high-power lasers for mission critical directed energy, optical sensing, and advanced manufacturing applications, today ...
Ready to unlock your full math potential? 🎓Subscribe for clear, fun, and easy-to-follow lessons that will boost your skills, build your confidence, and help you master math like a genius—one step at ...
AVENTURA, Fla.--(BUSINESS WIRE)--Immersion Corporation (“Immersion”, the “Company”, “we”, “us” or “our”) (Nasdaq: IMMR), a leading provider of ...
The International Financial Reporting Standards Foundation has published a set of near-final examples showing how companies can improve the reporting of uncertainties in their financial statements ...
TROPOS is a randomized, double-blind, placebo-controlled, global Phase 2 clinical trial to evaluate cibotercept in combination with background therapy in patients with PAH. On December 12, 2024, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results